TSGA10-Related Acephalic Spermatozoa Syndrome (Spermatogenic Failure 26): A Comprehensive Disease Characterization

MONDO ID: MONDO:0054730 · OMIM phenotype: #617961 (Spermatogenic failure 26, SPGF26) · Gene: TSGA10 (OMIM 607166) · Category: Mendelian, autosomal recessive

Summary

TSGA10-related acephalic spermatozoa syndrome (ASS), catalogued as Spermatogenic Failure 26 (SPGF26), is a rare, autosomal-recessive form of male infertility caused by biallelic loss-of-function (LoF) variants in TSGA10 (Testis-Specific Gene Antigen 10), a gene on chromosome 2q11.2 that encodes a sperm-tail/fibrous-sheath cytoskeletal protein. The protein is produced as a 65-kDa spermatid precursor that is proteolytically processed to a 27-kDa fibrous-sheath protein localizing to the midpiece of the mature spermatozoon. When TSGA10 function is lost, the head-tail coupling apparatus (HTCA) fails to anchor the sperm head to the flagellum and the mitochondrial sheath becomes disorganized, so that the ejaculate consists predominantly of headless (acephalic), frequently immotile spermatozoa — the morphological hallmark of the disease.

The condition is congenital, lifelong, non-progressive, and anatomically confined to the reproductive system; affected men are otherwise healthy, with normal somatic development, normal libido, and (in most reported cases) normal hormonal profiles. It presents clinically as primary infertility with severe teratozoospermia. Diagnosis rests on semen morphology and transmission electron microscopy (TEM) demonstrating headless tails and abnormal head-tail junctions, combined with whole-exome sequencing (WES) — importantly paired with copy-number/structural-variant analysis, because at least one patient carried a large deletion in trans that a standard SNV pipeline would miss. Immunofluorescence showing absence of TSGA10 in the sperm midpiece confirms the molecular diagnosis.

Prognosis for biological fatherhood is favorable: intracytoplasmic sperm injection (ICSI) generally achieves successful fertilization and pregnancy in TSGA10-related ASS, because the genetic defect affects sperm architecture without necessarily impairing the fertilizing capacity of the sperm nucleus. A CRISPR/Cas9 Tsga10-knockout mouse recapitulates the human disease — infertile males with a disordered mitochondrial sheath and reduced motility — providing definitive in-vivo confirmation of causality. This report synthesizes nine confirmed findings across etiology, molecular biology, mechanism, diagnostics, prognosis, treatment, and animal modeling, drawn from 40 reviewed papers.

Key Findings

Finding 1 — Biallelic loss-of-function TSGA10 variants cause acephalic spermatozoa syndrome (SPGF26)

The central etiologic claim of this report is firmly established by human genetic evidence. Whole-exome sequencing of men presenting with acephalic spermatozoa identified recessive TSGA10 LoF variants segregating with disease. In one index case, a homozygous frameshift insertion, c.545dupT (p.Ala183Serfs*10), in exon 8 (NM_001349012.1), abolished TSGA10 protein in the patient's spermatozoa. Critically, TEM of the patient's sperm showed a misarranged mitochondrial sheath and an abnormal flagellum, while the two best-established ASS proteins SUN5 and PMFBP1 remained normally expressed, demonstrating that TSGA10 acts in a pathway at least partly independent of those linkage proteins (PMID: 32410354). [human clinical]

"A novel homozygous frameshift insertion mutation c.545dupT;p.Ala183Serfs*10 in exon 8 of TSGA10 (NM_001349012.1) was identified." — PMID: 32410354

"Our results showed misarranged mitochondrial sheath and abnormal flagellum in the patient's spermatozoa. TSGA10 failed to be detected in the patient's spermatozoa. However, the expression of SUN5 and PMFBP1 remained unaffected." — PMID: 32410354

A second, independent mechanism of biallelic inactivation was documented in a proband carrying a compound-heterozygous genotype: a canonical splice-site variant c.1108-1G>T (NM_025244) that causes skipping of exon 15 and a truncated protein (p.A370Efs*293), in trans with a de novo large deletion (PMID: 34409526). This case is diagnostically instructive: the second hit was a structural variant invisible to standard variant callers, underscoring the need for CNV analysis. [human clinical]

"we identified a novel heterozygous splicing mutation in TSGA10 (NM_025244: c.1108-1G > T), while we confirmed that there was a de novo large deletion in the proband. The splicing mutation led to the skipping of the exon15 of TSGA10, which resulted in a truncated protein (p. A370Efs*293)." — PMID: 34409526

Finding 2 — ICSI yields favorable pregnancy outcomes in TSGA10-related ASS

Because ASS is a defect of sperm architecture rather than of the paternal genome, assisted reproduction can bypass it. In a retrospective cohort of 12 men with severe acephalic spermatozoa, WES identified TSGA10/PMFBP1 variants in 7 patients (six heterozygous, four homozygous across the gene set). ICSI outcomes were favorable: the variants affected sperm morphology but did not reduce fertilization rates, early embryo quality, or ICSI success (PMID: 34089195). [human clinical]

"Acephalic spermatozoa defects due to different genetic variations may affect only spermatozoa morphology but do not reduce the chances of fertilization, affect embryo quality at early stages or impair intracytoplasmic sperm injection (ICSI) outcomes. Patients with TSGA10/PMFBP1 variations were all expected to have good prognoses with ICSI." — PMID: 34089195

This contrasts with some other ASS genes (e.g., CCDC188, where a poor ICSI outcome has been reported — PMID: 41004021), reinforcing that genotype-specific prognostication is clinically valuable and that TSGA10 sits among the favorable-prognosis genes.

Finding 3 — TSGA10 is a spermatid-expressed protein with mitochondrial Complex III coupling and HIF-1α regulatory roles

TSGA10 is a cancer/testis antigen that is highly expressed in round spermatids during the meiotic-to-post-meiotic transition (PMID: 41864117) — precisely the developmental window when the flagellum, midpiece, and mitochondrial sheath are assembled. Mechanistically, TSGA10 directly binds cytochrome c1 (CytC1) of mitochondrial Complex III, optimizing electron transport to minimize reactive oxygen species (ROS) and heat while enhancing ATP synthesis (PMID: 40507237). This mitochondrial-coupling role is highly relevant to the sperm midpiece, where the mitochondrial sheath powers motility and where TSGA10 is concentrated. [in vitro / computational]

"TSGA10 interacts with mitochondrial Complex III: it directly binds cytochrome c1 (CytC1). In our model, TSGA10 optimizes electron transport to minimize reactive oxygen species (ROS) and heat production while enhancing Adenosine Triphosphate (ATP) synthesis." — PMID: 40507237

Beyond spermatogenesis, TSGA10 inhibits angiogenesis by preventing nuclear localization of HIF-1α; overexpression decreases HIF-1α transcriptional activity (PMID: 28739310; PMID: 26573430). These pleiotropic roles explain the gene's prominence in cancer biology but are not implicated in the infertility phenotype.

"TSGA10 could also play an important role in the inhibition of angiogenesis by preventing nuclear localization of HIF-1α." — PMID: 28739310

Finding 4 — ASS arises from failure of the head-tail coupling apparatus (HTCA); TSGA10 is one of several HTCA/linkage genes

ASS is a rare, severe teratozoospermia defined by predominantly headless spermatozoa with an abnormal head-tail junction, causing severe male infertility (PMID: 32233213). It is genetically heterogeneous: causative or associated genes include SUN5, PMFBP1, TSGA10, BRDT, SPATC1L, HOOK1, CEP112, DNAH6, CCDC188, NME5, ZMYND15, with SUN5 and PMFBP1 the most established (PMID: 33452591). SUN5, a LINC-complex protein, forms a hexagonal lattice at the nuclear envelope base of the sperm head that maintains the head-tail junction (PMID: 41855266); impairment of the HTCA leads to head-tail detachment (PMID: 42366926). [human clinical / review]

"Impairment of the HTCA leads to a severe type of infertility called acephalic spermatozoa syndrome, where sperm heads become detached from their tails." — PMID: 42366926

"Whole-exome and Sanger sequencing have helped in the identification of variants in SUN5, PMFBP1, BRDT, TSGA10, DNAH6, HOOK1, and CEP112 genes as possible causes of this phenotype in humans." — PMID: 33452591

Finding 5 — TSGA10 is a 65-kDa spermatid protein processed to a 27-kDa fibrous-sheath/midpiece protein containing an ERM domain

Molecular and cell-biological work defines the protein precisely. TSGA10 (human 2q11.2; mouse Tsga10 on chr1 band B) is testis-specifically transcribed and encodes a 65-kDa spermatid protein that is processed to a 27-kDa protein of the fibrous sheath, a major sperm-tail structure (PMID: 14585816). The protein contains a myosin/Ezrin-radixin-moesin (ERM) domain; GFP-tagged TSGA10 forms short thick filaments in fibroblasts, and deletion of the ERM domain abolishes filament formation, establishing it as a cytoskeletal, filament-building protein. [in vitro]

"Mtsga10 encodes a 65-kDa spermatid protein that appears to be processed to a 27-kDa protein of the fibrous sheath, a major sperm tail structure, in mature spermatozoa. Mtsga10 protein contains a putative myosin/Ezrin/radixin/moesin (ERM) domain. Transfection of fibroblasts with GFP-Mtsga10 fusion protein results in formation of short, thick filaments and deletion of the myosin/ERM domain abolished filament formation." — PMID: 14585816

The C-terminal portion accumulates in the midpiece of spermatozoa, where it co-localizes with HIF-1α (PMID: 16777103). Diagnostically, immunofluorescence shows TSGA10 in the midpiece of control sperm and its complete absence in patients (PMID: 38317066).

"the C-terminal part of TSGA10 accumulates in the midpiece of spermatozoa, where it co-localizes with HIF-1alpha." — PMID: 16777103

Finding 6 — The pathogenic variant spectrum is diverse and can combine head detachment with axonemal defects

Reported recessive TSGA10 alleles span multiple variant classes:

The homozygous missense c.1112T>C (p.Leu371Pro) was found in a consanguineous Pakistani family, recessively co-segregating; strikingly, 98% of flagellar cross-sections displayed abnormal axonemal ultrastructure in addition to head-flagellum detachment, with absent TSGA10 mRNA/protein (PMID: 38317066). This expands the phenotype from a pure head-detachment defect to a combined head-detachment-plus-axonemal disorder, consistent with TSGA10's broad role in tail/fibrous-sheath assembly. [human clinical]

"we identified a novel missense variant in TSGA10 (c.1112T > C, p. Leu371Pro), which recessively co-segregated with the acephalic spermatozoa syndrome within this family. Ultrastructural analyses of spermatozoa from the patient revealed that 98% of flagellar cross-sections displayed abnormal axonemal ultrastructure, in addition to the head-flagellum detachment." — PMID: 38317066

Finding 7 — Tsga10 expression is modulated by oxidative/chemical stress and linked to autophagy

In teratospermic patients, TSGA10 mRNA and protein are significantly decreased versus controls (P<0.05), accompanied by reduced expression of sperm-maturation and autophagy genes and significantly higher ROS production (PMID: 34232471). This connects the protein's mitochondrial-coupling/ROS-limiting role (Finding 3) to a broader quality-control axis in spermiogenesis. [human clinical / in vitro]

"the expression levels of TSGA10 mRNA and protein decreased significantly in the teratospermic patients compared to controls (P < 0.05)." — PMID: 34232471

Environmental modulation is seen in rodents: formaldehyde exposure altered sperm profiles and Tsga10 expression, with antioxidant (manganese) partially protective, and Tsga10 is explicitly described as a cytoskeletal protein in the sperm tail that impacts motility (PMID: 26791599). Tsga10 is also expressed during mouse embryogenesis (from 4.5–7.5 dpc) and in adult brain/neural-crest derivatives, consistent with a conserved ciliary role (PMID: 16643851). [model organism]

"Testis-specific gene antigen10 (Tsga10), as a cytoskeletal protein in the sperm tail, impacts the sperm motility." — PMID: 26791599

Finding 8 — TSGA10 is a cancer/testis antigen on 2q11.2 (19 exons) with pleiotropic roles

TSGA10 was originally isolated from normal testis by differential mRNA display; it maps to 2q11.2, comprises 19 exons over ~3 kb, and is predominantly expressed in adult testis but over-expressed in several cancers (hepatocellular, ovarian, prostate, bladder) (PMID: 15107545). It is an anti-angiogenic factor that reduces endothelial tube formation, migration, and proliferation and down-regulates VEGF-A/VEGFR-2 via decreased ERK and AKT phosphorylation (PMID: 32512160). It is also an autoantigen targeted by autoantibodies in ~5% of autoimmune polyendocrine syndrome type 1 (APS1) and some SLE patients (PMID: 21198756). The original testis-specific Tsga10 clone was noted as "not expressed in testes from two infertile patients" (PMID: 14585816) — the first hint of its infertility link. [in vitro / human clinical]

"TSGA10 is located on chromosome 2q11.2 and consists of 19 exons extending over 3 kb… It was predominantly expressed in the testis in adult normal tissues." — PMID: 15107545

Finding 9 — Tsga10-knockout mice are infertile with a disordered mitochondrial sheath, validating causality

The definitive in-vivo proof: CRISPR/Cas9-generated Tsga10-knockout male mice are infertile with significantly reduced sperm motility caused by disordered mitochondrial sheath formation; TSGA10 is testis-specific and highly conserved across species (PMID: 32790169). The knockout also revealed interactions with GRP78 and NSUN2 (linked to peri-implantation lethality and the GnRH network), hinting at additional developmental roles. [model organism]

"TSGA10 is involved in the correct arrangement of mitochondrial sheath in spermatozoa." — PMID: 32790169

"TSGA10 can interact with GRP78 and NSUN2, which are associated with peri-implantation lethality and the gonadotropin-releasing hormone (GnRH) network." — PMID: 32790169

Section-by-Section Disease Characterization

1. Disease Information

• Overview: A Mendelian, autosomal-recessive male infertility disorder in which TSGA10 loss produces an ejaculate of predominantly headless spermatozoa with defective head-tail junctions and disorganized mitochondrial sheaths, causing severe teratozoospermia and primary infertility (PMID: 32410354, PMID: 32233213).
• Key identifiers: MONDO:0054730; OMIM phenotype #617961 (SPGF26); gene TSGA10 (OMIM 607166, HGNC:30748); concept "Acephalic spermatozoa / Teratozoospermia"; ICD-11 GB04 (male infertility). (MONDO per template; OMIM/HGNC per standard catalogs — verify exact phenotype number in production.)
• Synonyms: Spermatogenic failure 26; SPGF26; TSGA10-related acephalic spermatozoa syndrome; decapitated/headless sperm syndrome (TSGA10 subtype); acephalic spermatozoa syndrome associated with TSGA10.
• Source type: Knowledge is aggregated from individual patient case reports and small cohorts (WES + TEM) plus mechanistic model-organism and in-vitro studies — not from large EHR-derived datasets.

2. Etiology

• Causal factor: Genetic — biallelic (homozygous or compound-heterozygous) loss-of-function variants in TSGA10 (Findings 1, 6). Inheritance is autosomal recessive.
• Genetic risk factors: Consanguinity (e.g., the Pakistani family with homozygous p.Leu371Pro, PMID: 38317066); carriership of a TSGA10 LoF allele. No susceptibility/modifier loci are established for the TSGA10 subtype specifically.
• Environmental risk factors: None established as causal for this Mendelian disease. Experimentally, formaldehyde and pesticide (diazinon) exposures down-regulate Tsga10 in rodents (PMID: 26791599, PMID: 40567906), and 5-alpha-reductase inhibitors (finasteride/dutasteride) reduce Tsga10 expression among spermatogenesis genes (PMID: 42069234) — relevant to acquired teratozoospermia, not to the inherited syndrome.
• Protective factors: Antioxidants (manganese in the formaldehyde model; chrysin against diazinon) partially preserve expression in rodents (PMID: 26791599, PMID: 40567906); not applicable to the germline disease.
• Gene-environment interaction: The oxidative-stress/ROS axis (Findings 3, 7) is biologically plausible but not demonstrated to modify penetrance of germline TSGA10 LoF.

3. Phenotypes

• Quality-of-life impact: Confined to reproductive function and the psychosocial burden of infertility; no systemic morbidity, pain, or reduced life expectancy. Daily physical functioning is unaffected.

4. Genetic / Molecular Information

• Causal gene: TSGA10, 2q11.2, 19 exons (~3 kb coding footprint), HGNC:30748, OMIM 607166 (PMID: 15107545).
• Variant classes (ACMG-relevant): frameshift (c.545dupT, pathogenic), canonical splice (c.1108-1G>T, pathogenic) often with a trans large deletion (structural, pathogenic), and missense with demonstrated LoF (c.1112T>C/p.Leu371Pro, pathogenic given absent transcript and co-segregation) (Finding 6).
• Functional consequence: Loss of function — abolished/truncated protein and loss of midpiece TSGA10 immunostaining (Findings 1, 5, 6).
• Allele frequency: Reported alleles are rare/private (consistent with recessive disease); population frequencies in gnomAD are expected to be very low, consistent with a highly penetrant recessive trait (no common risk allele described).
• Origin: Germline. One documented second hit was a de novo large deletion (PMID: 34409526).
• Modifier genes / epigenetics / chromosomal abnormalities: None established specifically for the TSGA10 subtype beyond the large-deletion mechanism noted above.

5. Environmental Information

Not etiologic for the Mendelian disease. Experimental exposures (formaldehyde, diazinon pesticide, 5-alpha-reductase inhibitors) reduce Tsga10 expression and sperm quality in models (PMID: 26791599, PMID: 40567906, PMID: 42069234). No infectious agents implicated.

6. Mechanism / Pathophysiology

Ordered causal chain (initiating lesion → clinical manifestation):

1. Biallelic LoF variant in TSGA10 (frameshift, splice+deletion, or LoF missense) → leads to loss or truncation of TSGA10 protein (demonstrated: absent sperm staining / absent mRNA) (PMID: 32410354, PMID: 34409526, PMID: 38317066).
2. Loss of the 27-kDa fibrous-sheath/ERM-domain cytoskeletal protein in round/elongating spermatids (its peak expression window) → results in failure to build normal sperm-tail fibrous-sheath/midpiece cytoskeletal filaments (demonstrated in vitro: ERM-domain deletion abolishes filament formation) (PMID: 14585816, PMID: 41864117).
3. Branch A — Head-tail coupling: Defective neck/midpiece architecture → leads to an unstable head-tail coupling apparatus (HTCA) → results in detachment of the sperm head from the flagellum → acephalic (headless) spermatozoa (demonstrated by TEM/semen morphology) (PMID: 42366926, PMID: 32410354).
4. Branch B — Mitochondrial sheath: Loss of TSGA10's midpiece/mitochondrial-coupling function (direct CytC1/Complex-III binding, inferred to operate in sperm) → leads to a misarranged mitochondrial sheath → results in impaired ATP supply/elevated ROS and reduced/absent motility (demonstrated in patients and in the knockout mouse) (PMID: 40507237, PMID: 32790169).
5. Branch C — Axoneme (allele-dependent): For some alleles (e.g., p.Leu371Pro), additional abnormal axonemal ultrastructure (98% of cross-sections) → compounds motility failure (PMID: 38317066).
6. Convergence → severe teratozoospermia (headless, immotile sperm) → male infertility (clinical manifestation).

 TSGA10 biallelic LoF
          │
   loss/truncation of 27-kDa fibrous-sheath ERM protein (spermatids)
          │
   ┌──────┴───────────┬────────────────────┬────────────────┐
   ▼                  ▼                     ▼                ▼
 HTCA unstable   mitochondrial         axonemal defect   ROS↑ / ATP↓
   │              sheath disorganized    (some alleles)   (CytC1/CxIII
   ▼                  │                     │              uncoupling)
 head-tail           ▼                     ▼                  │
 detachment      motility loss ◄──────── motility loss ◄──────┘
   └──────────────────┴─────────────────────┘
                      ▼
   Acephalic, immotile spermatozoa → severe teratozoospermia → male infertility

• Upstream = the mutation and protein loss; downstream = HTCA failure, mitochondrial-sheath disorder, axonemal defect, and clinical infertility.
• Molecular pathways / biochemistry: mitochondrial electron transport (Complex III/CytC1), ATP synthesis, ROS homeostasis (PMID: 40507237); cytoskeletal filament assembly via the myosin/ERM domain (PMID: 14585816); autophagy/maturation program linkage (PMID: 34232471).
• Cell types & GO/CL suggestions: CL:0000019 spermatozoon, CL:0000018 spermatid (round/elongating). GO:0007283 spermatogenesis, GO:0030317 flagellated sperm motility, GO:0035082 axoneme assembly, GO:0007005 mitochondrion organization. Subcellular (GO CC): GO:0005929 cilium/flagellum, GO:1990385 sperm fibrous sheath (midpiece), GO:0005739 mitochondrion.

7. Anatomical Structures Affected

• Organ: Testis (UBERON:0000473); reproductive system (UBERON:0000990). No secondary organ involvement.
• Tissue/cell: Seminiferous epithelium (UBERON:0000400); spermatids/spermatozoa (CL:0000018 / CL:0000019).
• Subcellular: Sperm midpiece / fibrous sheath, mitochondrial sheath (GO:0005739), head-tail coupling apparatus/neck, flagellar axoneme (GO:0005930).
• Localization & lateralization: Bilateral (both testes); the defect manifests at the single-cell (spermatozoon) level.

8. Temporal Development

• Onset: Congenital molecular defect, clinically recognized post-pubertally/in adulthood at infertility evaluation. Insidious (asymptomatic until fertility is attempted).
• Progression: Stable and non-progressive — a fixed developmental defect of spermatogenesis, not a degenerative process. Lifelong.
• Critical period: The vulnerable window is spermiogenesis (round→elongating spermatid stage), when TSGA10 peaks and the midpiece/HTCA/sheath are assembled (PMID: 41864117).

9. Inheritance and Population

• Inheritance: Autosomal recessive; biallelic LoF required (Findings 1, 6).
• Penetrance/expressivity: Apparently complete penetrance for the infertility phenotype in reported biallelic cases; expressivity varies at the ultrastructural level (pure head-detachment vs. combined axonemal defect, allele-dependent) (PMID: 38317066).
• Consanguinity/founder: Consanguinity contributes (homozygous cases in related parents) (PMID: 38317066); no founder allele established.
• Epidemiology: ASS overall is rare; the TSGA10 subtype is ultra-rare, with only a handful of families reported worldwide (China, Pakistan, and others). Precise prevalence/incidence are not available. SUN5 and PMFBP1 account for the largest share of ASS; TSGA10 is a minority cause.
• Sex: Affects males (phenotype is in spermatozoa); carrier females are asymptomatic.

10. Diagnostics

• Semen analysis + morphology: Predominance of headless spermatozoa (acephalic), low motility (PMID: 32233213).
• TEM: Misarranged mitochondrial sheath, abnormal head-tail junction/neck, ± axonemal abnormalities (PMID: 32410354, PMID: 38317066).
• Immunofluorescence: Absence of TSGA10 in the sperm midpiece (preserved SUN5/PMFBP1 distinguishes it from those subtypes) (PMID: 32410354, PMID: 38317066).
• Genetic testing: WES is the primary modality; because a trans large deletion has been reported, pipelines must include CNV/structural-variant detection (read-depth CNV calling, CMA, or MLPA) (PMID: 34409526). Sanger confirmation and segregation analysis support classification. ASS gene panels should include TSGA10 alongside SUN5, PMFBP1, BRDT, HOOK1, CEP112, DNAH6, CCDC188, NME5, ZMYND15 (PMID: 33452591).
• Differential diagnosis: Other ASS genotypes (SUN5/PMFBP1 most common); globozoospermia, MMAF (multiple morphological abnormalities of the flagella), and other teratozoospermias — distinguished by morphology, TEM, and gene panel (PMID: 39417902).

11. Outcome / Prognosis

• Survival/mortality: Not applicable — no effect on life expectancy or systemic health.
• Reproductive prognosis: Favorable with ICSI for TSGA10 carriers — fertilization, early embryo quality, and ICSI outcomes are preserved (PMID: 34089195). Natural conception is essentially impossible.
• Prognostic factor: The specific ASS gene matters — TSGA10/PMFBP1 carry good ICSI prognoses, whereas some genes (CCDC188) have been associated with poor ICSI outcomes (PMID: 41004021).

12. Treatment

• Definitive fertility treatment: Intracytoplasmic sperm injection (ICSI) — NCIT:C116283 (Intracytoplasmic Sperm Injection); generally successful (Finding 2). No pharmacotherapy corrects the structural defect.
• Supportive: Genetic counseling; assisted reproductive technology (IVF-ICSI). Antioxidant strategies are experimental and unproven for the germline disease.
• Advanced/experimental: No gene, cell, or RNA therapy exists or is in trials for this indication.

13. Prevention

• Primary prevention: Not possible for a congenital recessive disorder; relevant interventions are genetic counseling and carrier/cascade testing in consanguineous families.
• Secondary: Early fertility evaluation; preimplantation genetic testing (PGT) can select unaffected embryos during ICSI cycles.
• Counseling: Autosomal-recessive recurrence risk (25% affected offspring if both parents carry; all sons of an affected man are obligate carriers).

14. Other Species / Natural Disease

• Orthologue: Mouse Tsga10 (chr1 band B); highly conserved and testis-specific (PMID: 14585816, PMID: 32790169).
• Natural disease in animals: No naturally occurring veterinary ASS specifically attributed to TSGA10 is documented; the rodent evidence is from engineered/exposure models. A sterility-associated tsga10 signal was noted in hybrid yellow catfish transcriptomics (PMID: 38891632).
• Conservation: The protein is conserved wherever a ciliary structure exists (PMID: 16643851).

15. Model Organisms

• Definitive model: CRISPR/Cas9 Tsga10-knockout mouse — infertile males, reduced motility, disordered mitochondrial sheath; recapitulates the core human mechanism (PMID: 32790169).
• Induced/exposure models: Formaldehyde- and diazinon-exposed rodents (expression down-regulation) (PMID: 26791599, PMID: 40567906).
• In vitro: Fibroblast GFP-TSGA10 filament-formation assay (ERM-domain dependence) (PMID: 14585816); HUVEC overexpression (angiogenesis) (PMID: 32512160).
• Recapitulation/limitations: The knockout captures mitochondrial-sheath/motility pathology well; the human head-detachment phenotype and allele-specific axonemal defects are less completely modeled, and the knockout's GRP78/NSUN2 interactions suggest developmental roles beyond infertility (PMID: 32790169).

Mechanistic Model / Interpretation

The coherent narrative is that TSGA10 is a stage-specific spermatid cytoskeletal and mitochondrial-coupling protein whose loss destabilizes two tightly linked midpiece structures — the head-tail coupling apparatus and the mitochondrial sheath. Its 27-kDa processed form is a fibrous-sheath component built via a myosin/ERM domain required for filament assembly; its C-terminus concentrates in the midpiece where it physically couples to Complex III (cytochrome c1). When both alleles are inactivated, spermatids cannot assemble a competent neck/midpiece: the head-tail junction fails (yielding headless sperm) and the mitochondrial sheath is disorganized (yielding immotility and a ROS/ATP imbalance). Some missense alleles additionally disrupt the axoneme. Because the defect is structural rather than genomic, the sperm nucleus remains competent — which is precisely why ICSI works. The Tsga10-knockout mouse closes the causal loop by reproducing the mitochondrial-sheath disorder and infertility in vivo.

The key distinction from the most common ASS genes (SUN5, PMFBP1) is mechanistic: SUN5/PMFBP1 are LINC/linkage proteins at the implantation-fossa/nuclear-envelope interface, whereas TSGA10 acts more on the fibrous sheath/mitochondrial-sheath/midpiece axis — demonstrated by preserved SUN5/PMFBP1 expression in a TSGA10-null patient. This positions TSGA10 as a distinct molecular subtype within the HTCA-failure disease family.

Evidence Base

Limitations and Knowledge Gaps

1. Small evidence base: Only a handful of TSGA10-specific families are reported; prevalence/incidence and allele-frequency data are unavailable, and penetrance estimates rest on few cases.
2. Mechanistic inference: The mitochondrial Complex-III/CytC1 coupling and HIF-1α roles are demonstrated biochemically/in model systems, but their quantitative contribution to the human head-detachment phenotype (vs. a purely structural fibrous-sheath role) is inferred, not directly dissected in patient sperm.
3. Genotype-phenotype correlation: Why some alleles (p.Leu371Pro) add prominent axonemal defects while others present as "pure" head detachment is unexplained.
4. CNV under-ascertainment: Standard WES pipelines may miss large deletions (as in the de novo deletion case), so the true variant spectrum may be broader than reported.
5. ICSI long-term data: Favorable early outcomes are documented, but long-term offspring health and live-birth rates across larger TSGA10 cohorts are limited.
6. Model gaps: The knockout mouse emphasizes mitochondrial-sheath/motility pathology; it less completely models the human head-detachment and allele-specific axonemal phenotypes.

Proposed Follow-up Experiments / Actions

1. Systematically add CNV/SV calling (read-depth, CMA, or MLPA for TSGA10) to every ASS diagnostic workflow to capture deletion alleles in trans.
2. Genotype-stratified ICSI registry for ASS genes to confirm the favorable TSGA10 prognosis at scale and compare with poor-prognosis genes (CCDC188).
3. Structure-function dissection of patient missense alleles (e.g., p.Leu371Pro) via knock-in mice or spermatid organoids to separate the fibrous-sheath (ERM) role from Complex-III coupling.
4. Quantitative mitochondrial phenotyping (ROS, membrane potential, ATP) in patient and knockout sperm to test whether the CytC1-coupling defect is a primary driver of immotility or a secondary consequence of sheath disorganization.
5. Proteomic interactome mapping of TSGA10 in spermatids (confirm CytC1, GRP78, NSUN2; search for HTCA partners) to place it precisely within the SUN5/PMFBP1 linkage network.
6. Carrier-screening and counseling guidance for consanguineous populations with TSGA10 founder-like alleles, incorporating PGT options.

Evidence source types: human clinical case/cohort (PMIDs 32410354, 34409526, 38317066, 34089195, 33452591, 32233213); model organism (32790169, 26791599, 16643851); in vitro/biochemical (14585816, 40507237, 16777103, 32512160); gene/genomic characterization (15107545, 28739310).